Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR
Status:
Completed
Trial end date:
2018-12-10
Target enrollment:
Participant gender:
Summary
Endovascular aneurysm repair (EVAR) was introduced in 1990 for the first time as a minimally
invasive procedure instead of the conventional open surgical repair, with the aim to decrease
morbidity and mortality . Nowadays EVAR has become an acceptable management for patients with
infra-renal aortic aneurysms (AAA) . A lot of anesthetic techniques have been used
successfully for EVAR. EVAR requires sedative analgesic medications to achieve an acceptable
level of comfort to the patient and cardiorespiratory stability.
This is prospective randomized single blinded study of patients presenting with aorto-iliac
aneurysm who will undergo EVAR. Patient's demographic data will be assessed, as well as
clinical presentation, intraoperative complications.
30 patients undergoing elective EVAR will be included and will be divided equally into 2
groups.
First group is the psoas compartment block (PCB) (15 patients): 30 ml of bupivacaine 0.25%
will be infused over 3 minutes at the anatomical landmark.
Second group is the LA and remifentanil group (LR) (15 patients): lidocaine 5 ml of 2% will
be injected subcutaneous as local infiltration then remifentanil infusion with rate 0.03-0.1
μg kg-1 min-1. to achieve visual analog scale (VAS) 3 or less.
Vital date will be recorded as baseline then every 5 minutes till the end of the procedure.
VAS will be recorded as baseline then every 5 minutes till the end of the procedure. Also
stress response which will be measured subjectively as vital data and VAS and objectively as
cortisol level in the blood which will be measured as base line and immediate after the end
of the procedure.